and 503Bs have until March 19 to call it quits
However, results can vary depending on individual factors including baseline weight, metabolic health, and adherence to the treatment plan
Navigating Glucagon-Like Peptide Receptor Agonist Reinitiation Amid Access Barriers: An Adverse Drug Event Case Report
Moreover, although randomized designs mitigate healthy-user bias, participants enrolled in long-term cardiovascular outcome trials may represent a healthier, more adherent subset of patients, potentially limiting generalizability
It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM
While a quarter of GLP-1 users said in the new study that they've cut back on all restaurant meals, dinner has taken the biggest hit